BlackRock Health Sciences Trust

BME

市值 US$5.69億

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

BlackRock Health Sciences Trust remains a steady income generator, never having cut its regular distribution since inception, despite recent lackluster results. BME's discount has narrowed, resulting in some outperformance relative to XLV on total share price return. I continue to hold BME for long-term income, viewing the current healthcare sector undervaluation as a potential opportunity for cautious, incremental additions.

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

BlackRock Health Sciences Trust is upgraded to a buy, benefiting from its shift to an equity-focused strategy and improved NAV growth prospects. BME offers an 8.3% monthly dividend yield, but coverage is inconsistent and reliant on net realized gains rather than stable investment income. Elimination of the option writing strategy positions BME to better capture upside in healthcare, especially with exposure to GLP-1 drug market leaders.

Healthcare dividend stocks are selling off with the turbulence in the Middle East.

I highlight seven closed-end funds, or CEFs, with rising NAVs and increasing distributions over the past 10–15 years, spanning diverse asset classes. These CEFs—PEO, BDJ, BME, CSQ, UTF, STK, and GDV—offer strong total returns, resilient income growth, and trade at attractive discounts to NAV. Funds like STK and CSQ have outperformed the S&P 500 on a 10-year total return basis, while others like BME and UTF have never cut distributions.

I highlight five additional CEFs—BIT, BME, BST, BUI, and GLU—that have never cut distributions for at least a decade, offering high-yield, monthly income. BIT yields nearly 12% at a -6.8% discount, but declining earnings coverage and rising ROC signal caution on distribution sustainability. BME, BST, and BUI trade at discounts and have recently increased distributions, with BST delivering an 18% 10-year total return at market price.

My closed-end fund portfolio update provides a more concentrated top 10, and that is on the back of a reduction in the number of holdings since last year. I remain leaning toward utility/infrastructure positioning, and that remains an attractive area of the market to generate predictable cash flows. In general, CEF discounts are fairly narrow compared to their historical levels, but the average discount has moved wider, at least slightly.